Review
Post-translational modification of Parkin and its research progress in cancer
Dan Ding, Xiang Ao, Ying Liu, Yuan-Yong Wang, Hong-Ge Fa, Meng-Yu Wang, Yu-Qi He & Jian-Xun Wang
[ [Abstract ] [ Abstract 186] [ PDF Full-text 171] [ PubMed] Epub: 11/21/2019 doi:10.1186/s40880-019-0421-5
Letter to the Editor
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone & Kazuo Kasahara
[ [Abstract ] [ Abstract 162] [ PDF Full-text 163] [ PubMed] Epub: 11/21/2019 doi:10.1186/s40880-019-0423-3
Original article
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang, Wei Fan, Xiang Guo, Ming-Huang Hong & Ming-Yuan Chen
[ [Abstract ] [ Abstract 177] [ PDF Full-text 165] [ PubMed] Epub: 11/15/2019 doi:10.1186/s40880-019-0415-3
Research highlight
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
Gunnar Folprecht
[ [Abstract ] [ Abstract 176] [ PDF Full-text 159] [ PubMed] Epub: 11/14/2019 doi:10.1186/s40880-019-0417-1
Study Protocol
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
hristian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer & Stephanie E. Combs
[ [Abstract ] [ Abstract 242] [ PDF Full-text 220] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0416-2
Research highlight
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
Trace M. Jones, Claudia Espitia, Wei Wang, Steffan T. Nawrocki & Jennifer S. Carew
[ [Abstract ] [ Abstract 177] [ PDF Full-text 165] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0418-0
Research highlight
Nuclear glycogenolysis modulates histone acetylation: a novel mechanism of epigenetic regulation in cancer
Xifeng Dong
[ [Abstract ] [ Abstract 204] [ PDF Full-text 161] [ PubMed] Epub: 11/9/2019 doi:10.1186/s40880-019-0420-6
Research highlight
CD137 expression in cancer cells: regulation and significance
Christophe Glorieux & Peng Huang
[ [Abstract ] [ Abstract 180] [ PDF Full-text 160] [ PubMed] Epub: 11/8/2019 doi:10.1186/s40880-019-0419-z
Study Protocol
The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang & Hongyun Zhao
[ [Abstract ] [ Abstract 185] [ PDF Full-text 169] [ PubMed] Epub: 11/7/2019 doi:10.1186/s40880-019-0414-4
Original article
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
Zhi-Xia Yue, Tian-Yu Xing, Chao Gao, Shu-Guang Liu, Wen Zhao, Qian Zhao, Xi-Si Wang, Mei Jin & Xiao-Li Ma
[ [Abstract ] [ Abstract 191] [ PDF Full-text 192] [ PubMed] Epub: 11/4/2019 doi:10.1186/s40880-019-0409-1
